Supaglutide
A Study of the Efficacy and Safety of Supaglutide in Healthy Participants
Shanghai Yinnuo Pharmaceutical Technology Co. · Phase 1 · Completed · Enrollment 48
| Arm | Nausea | Vomiting | Diarrhea | Discontinuation | Deaths |
|---|---|---|---|---|---|
| 0.15mg Supaglutide or placebo | n/r | n/r | n/r | n/r | n/r |
| 0.375mg Supaglutide or placebo | n/r | n/r | n/r | n/r | n/r |
| 0.75mg Supaglutide or placebo | n/r | n/r | n/r | n/r | n/r |
| 1.5mg Supaglutide or placebo | n/r | n/r | n/r | n/r | n/r |
| 3.0mg Supaglutide or placebo | n/r | n/r | n/r | n/r | n/r |
A count stays a count. This page does not turn a count into a percent.